Loading…
InterCure Ltd. is projected to rise to $1.13 by 2027, a +18% move from its current price of $0.9529. INCR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.9201 | $0.9536 | $0.9883 | +0.07% |
| Aug 6 | $0.9072 | $0.9543 | $1.00 | +0.14% |
| Aug 7 | $0.8976 | $0.9549 | $1.02 | +0.21% |
| Aug 8 | $0.8896 | $0.9556 | $1.03 | +0.29% |
| Aug 9 | $0.8828 | $0.9563 | $1.04 | +0.36% |
| Aug 10 | $0.8767 | $0.957 | $1.04 | +0.43% |
| Aug 11 | $0.8712 | $0.9577 | $1.05 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8712 | $0.9577 | $1.05 | +0.50% |
| Week 2 | $0.8419 | $0.9625 | $1.10 | +1.01% |
| Week 3 | $0.821 | $0.9673 | $1.14 | +1.51% |
| Week 4 | $0.8045 | $0.9722 | $1.17 | +2.02% |
| Week 5 | $0.7907 | $0.9771 | $1.21 | +2.54% |
| Week 6 | $0.7787 | $0.982 | $1.24 | +3.05% |
| Week 7 | $0.7682 | $0.9869 | $1.27 | +3.57% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InterCure Ltd. is a healthcare company that, together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
InterCure operates within the healthcare sector, focusing on medical cannabis products and related biomedical interests. These activities place it in the broader pharmaceutical and biotech landscape with a regional emphasis on Israel and an international footprint.
InterCure Ltd. (INCR) is currently trading at $0.916 per share and has a market cap of $52.35M. It ranks 4372 in market capitalization. The near-term price outlook shows a bearish setup, but the longer-run forecast envisions gradual upside across multiple years, with the average price rising from $0.916 in 2026 toward higher levels by 2050.
The forecast captures a year-by-year path: 2026 avg $0.916; 2027 avg $1.05; 2028 avg $1.13; 2029 avg $1.09; 2030 avg $1.09; 2031 avg $1.34; 2032 avg $1.65; 2033 avg $1.76; 2034 avg $1.66; 2035 avg $1.71; 2040 avg $2.54; 2050 avg $5.10. The outlook includes rising max values and sizable returns later in the horizon, with a long-run max of $10.64 in 2050 and a 2050 avg of $5.10.
A major floor 23.4% below — a decisive break under it would weaken the trend.
The nearest floor, 8.1% below — buyers have tended to step in here.
The nearest ceiling, 18.6% above — a clean break opens room to run.
A major ceiling 30.5% above — clearing it would confirm fresh momentum.
Key INCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.9218 | Buy | $0.9362 | Buy |
| MA 10 | $0.9285 | Buy | $0.9367 | Buy |
| MA 20 | $0.947 | Buy | $0.949 | Buy |
| MA 50 | $0.9752 | Sell | $0.9481 | Buy |
| MA 100 | $0.8857 | Buy | $0.9501 | Buy |
| MA 200 | $1.02 | Sell | $1.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.08 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 39.09 | Neutral |
| Williams %R (14) | -24.56 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 0.73 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 75.44 | Neutral |
| TRIX (15) | -0.20 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 52.00 | Neutral |
| Momentum (10) | 0.05 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.92 | Buy |
| ADX (14) | 9.78 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is BEARISH. RSI14 sits at 40, indicating modest momentum on the near term. The price action is currently trading near the SMA50 of $0.9558 and below the SMA200 of $1.05, framing near-term resistance around $1.13 and support at $0.85.
The 30-day range spans from $0.7189 to $1.17, illustrating recent volatility within a relatively tight band around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.73 | $0.9618 | $1.33 | 0% | Neutral | |
| $0.8794 | $1.13 | $1.56 | +18% | Neutral | |
| $0.9008 | $1.21 | $1.74 | +26% | Bullish | |
| $0.847 | $1.17 | $1.75 | +22% | Bullish | |
| $0.8781 | $1.25 | $1.93 | +30% | Bullish | |
| $1.01 | $1.48 | $2.35 | +54% | Bullish | |
| $1.22 | $1.83 | $2.97 | +91% | Bullish | |
| $1.34 | $2.05 | $3.40 | +113% | Bullish | |
| $1.20 | $1.88 | $3.17 | +95% | Bullish | |
| $1.21 | $1.94 | $3.33 | +101% | Bullish | |
| $1.69 | $2.97 | $5.51 | +209% | Bullish | |
| $2.91 | $6.12 | $12.62 | +536% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.73 | $0.9618 | $1.19 | +0.93% |
| September 2026 | $0.8625 | $1.03 | $1.27 | +7.01% |
| October 2026 | $0.8447 | $1.02 | $1.27 | -1.17% |
| November 2026 | $0.8228 | $0.9981 | $1.26 | -1.87% |
| December 2026 | $0.8512 | $1.04 | $1.33 | +4.16% |
Click any year to see its month-by-month INCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INCR to range from $0.73 to $1.33 through 2026. The $0.9618 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INCR price prediction for 2027 points to an average of $1.13 (low $0.8794, high $1.56) — a potential gain of +18% on today's $0.9529. Price action looks broadly range-bound.
In 2028, INCR is projected to trade between $0.9008 and $1.74, averaging $1.21 — a potential gain of +26% from today's $0.9529. That is up +6% on the projected 2027 average. Buyers look set to stay in control over this stretch.
InterCure Ltd.'s 2029 outlook centres on $1.17, within a $0.847 to $1.75 range. That is -3% versus the projected 2028 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2030, INCR could reach as high as $1.93, with a base case around $1.25 and support toward $0.8781 — roughly +30% from $0.9529. Buyers look set to stay in control over this stretch.
Expect INCR to range from $1.01 to $2.35 through 2031. The $1.48 average target implies a +54% move from current prices. That is up +18% on the projected 2030 average. Momentum favours further upside here.
The INCR price prediction for 2032 points to an average of $1.83 (low $1.22, high $2.97) — a potential gain of +91% on today's $0.9529. Buyers look set to stay in control over this stretch.
In 2033, INCR is projected to trade between $1.34 and $3.40, averaging $2.05 — a potential gain of +113% from today's $0.9529. That is up +12% on the projected 2032 average. Momentum favours further upside here.
InterCure Ltd.'s 2034 outlook centres on $1.88, within a $1.20 to $3.17 range. That is -9% versus the projected 2033 average. That marks a +95% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, INCR could reach as high as $3.33, with a base case around $1.94 and support toward $1.21 — roughly +101% from $0.9529. Momentum favours further upside here.
Expect INCR to range from $1.69 to $5.51 through 2040. The $2.97 average target implies a +209% move from current prices. That is up +54% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INCR price prediction for 2050 points to an average of $6.12 (low $2.91, high $12.62) — a potential gain of +536% on today's $0.9529. Momentum favours further upside here.
Investing $1,000 in INCR today (≈ 1,049.428062 INCR) could be worth
$6,423.91
+$5,423.91 (+542%) by 2050 · US Dollar
Based on the average projected INCR price of $6.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INCRwould be worth at today's price.
$1,000 invested in INCR on Jul 31, 2025 (≈ 699.300725 INCR) would be worth
$666.36
-$333.64 (-33.4%) today · 0.67× · US Dollar
Based on a INCR entry price of $1.43 vs. today's $0.9529.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.966 | $986.44 | -1.4% |
| 1 month ago | $1.13 | $843.27 | -15.7% |
| 3 months ago | $0.888 | $1,073.09 | +7.3% |
| 6 months ago | $0.939 | $1,014.8 | +1.5% |
| 1 year ago | $1.43 | $666.36 | -33.4% |
| All time (5.0y) ago | $6.5 | $146.6 | -85.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INCR forecast.
Our base-case forecast reaches $1.90 around 2033.
Implied market cap at $1.90: $112.53M
The multi-year outlook shows meaningful upside in the outer years. For 2030, the AVG price is $1.09 with a ROI of 18.9% and sentiment NEUTRAL. In 2031 the AVG rises to $1.34 with ROI 45.8% and sentiment BULLISH, followed by 2032 AVG $1.65 (ROI 79.9%), 2033 AVG $1.76 (ROI 92%), 2034 AVG $1.66 (ROI 80.8%), and 2035 AVG $1.71 (ROI 86.5%), all with BULLISH sentiment from 2031 onward.
Looking further out, 2040 shows AVG $2.54 with ROI 177% and sentiment BULLISH, and 2050 shows AVG $5.10 with ROI 456.7% and sentiment BULLISH. The implied price path suggests rising price levels and substantial upside potential by mid-century, albeit with the usual uncertainty around long-term forecasts. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
2030 avg price is $1.09; min $0.7589; max $1.69; ROI 18.9%; sentiment NEUTRAL.
Forecasts imply upside over the horizon, with 2050 avg $5.10 and max $10.64 and ROI up to 456.7%, but near-term sentiment is NEUTRAL and these are estimates, not guarantees.
Yes. The 2050 forecast shows a max of $10.64 and an avg of $5.10, indicating potential to reach or exceed $5 in that horizon, though it is not guaranteed.
Current price is $0.916. Near-term sentiment is BEARISH; RSI 40; SMA50 is $0.9558 and SMA200 is $1.05, with a 30-day range from $0.7189 to $1.17 and near-term support at $0.85 and resistance at $1.13.
2040 min $1.42; avg $2.54; max $4.75; ROI 177; sentiment BULLISH.
InterCure Ltd. Community Discussion
0Share your InterCure Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.